These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 35343625)

  • 1. The role of astrocytes in epileptic disorders.
    Hayatdavoudi P; Hosseini M; Hajali V; Hosseini A; Rajabian A
    Physiol Rep; 2022 Mar; 10(6):e15239. PubMed ID: 35343625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant Connection Formation and Glia Involvement in the Progression of Pharmacoresistant Mesial Temporal Lobe Epilepsy.
    Vega-García A; Guevara-Guzmán R; García-Gómez O; Feria-Romero I; Fernández-Valverde F; Alonso-Vanegas M; Orozco-Suárez S
    Curr Pharm Des; 2022; 28(28):2283-2297. PubMed ID: 35713147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of astrocyte glutamine synthetase in epilepsy.
    Eid T; Tu N; Lee TS; Lai JC
    Neurochem Int; 2013 Dec; 63(7):670-81. PubMed ID: 23791709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippocampal neuron loss and astrogliosis in medial temporal lobe epileptic patients with mental disorders.
    Lu J; Huang H; Zeng Q; Zhang X; Xu M; Cai Y; Wang Q; Huang Y; Peng Q; Deng L
    J Integr Neurosci; 2019 Jun; 18(2):127-132. PubMed ID: 31321953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate and astrocytes--key players in human mesial temporal lobe epilepsy?
    Eid T; Williamson A; Lee TS; Petroff OA; de Lanerolle NC
    Epilepsia; 2008; 49 Suppl 2():42-52. PubMed ID: 18226171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacoresistance with newer anti-epileptic drugs in mesial temporal lobe epilepsy with hippocampal sclerosis.
    Pohlen MS; Jin J; Tobias RS; Maheshwari A
    Epilepsy Res; 2017 Nov; 137():56-60. PubMed ID: 28941835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factors.
    Kuzmanovski I; Cvetkovska E; Babunovska M; Kiteva Trencevska G; Kuzmanovska B; Boshkovski B; Isjanovska R
    Clin Neurol Neurosurg; 2016 May; 144():91-5. PubMed ID: 27037863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inter-individual variation in the effect of antiepileptic drugs in the intrahippocampal kainate model of mesial temporal lobe epilepsy in mice.
    Klein S; Bankstahl M; Löscher W
    Neuropharmacology; 2015 Mar; 90():53-62. PubMed ID: 25460186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic profile differentiating between mesial temporal lobe epilepsy with and without hippocampal sclerosis.
    Furukawa A; Kakita A; Chiba Y; Kitaura H; Fujii Y; Fukuda M; Kameyama S; Shimada A
    Epilepsy Res; 2020 Dec; 168():106502. PubMed ID: 33197783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An 18-year follow-up of seizure outcome after surgery for temporal lobe epilepsy and hippocampal sclerosis.
    Hemb M; Palmini A; Paglioli E; Paglioli EB; Costa da Costa J; Azambuja N; Portuguez M; Viuniski V; Booij L; Nunes ML
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):800-5. PubMed ID: 23408065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TLR4, ATF-3 and IL8 inflammation mediator expression correlates with seizure frequency in human epileptic brain tissue.
    Pernhorst K; Herms S; Hoffmann P; Cichon S; Schulz H; Sander T; Schoch S; Becker AJ; Grote A
    Seizure; 2013 Oct; 22(8):675-8. PubMed ID: 23706953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of brain metabolism changes in mesial temporal lobe epilepsy.
    Chassoux F; Artiges E; Semah F; Desarnaud S; Laurent A; Landre E; Gervais P; Devaux B; Helal OB
    Epilepsia; 2016 Jun; 57(6):907-19. PubMed ID: 27061896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics analysis reveals multiple functional changes in astrocytes in temporal lobe epilepsy.
    Li D; Wang Y; Guo Y; Wang W
    Brain Res; 2024 May; 1831():148820. PubMed ID: 38417653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive impairment and drug responsiveness in mesial temporal lobe epilepsy.
    Celiker Uslu S; Yuksel B; Tekin B; Sariahmetoglu H; Atakli D
    Epilepsy Behav; 2019 Jan; 90():162-167. PubMed ID: 30576963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of astrocytes in temporal lobe epilepsy.
    Steinhäuser C; Grunnet M; Carmignoto G
    Neuroscience; 2016 May; 323():157-69. PubMed ID: 25592426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The subiculum and its role in focal epileptic disorders.
    Lévesque M; Avoli M
    Rev Neurosci; 2021 Apr; 32(3):249-273. PubMed ID: 33661586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonizing Increased
    Vangoor VR; Reschke CR; Senthilkumar K; van de Haar LL; de Wit M; Giuliani G; Broekhoven MH; Morris G; Engel T; Brennan GP; Conroy RM; van Rijen PC; Gosselaar PH; Schorge S; Schaapveld RQJ; Henshall DC; De Graan PNE; Pasterkamp RJ
    J Neurosci; 2019 Jun; 39(26):5064-5079. PubMed ID: 31015341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mTOR pathway is activated in glial cells in mesial temporal sclerosis.
    Sosunov AA; Wu X; McGovern RA; Coughlin DG; Mikell CB; Goodman RR; McKhann GM
    Epilepsia; 2012 Jun; 53 Suppl 1():78-86. PubMed ID: 22612812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of mTOR in Reactive Astrocytes Suppresses Chronic Seizures in a Mouse Model of Temporal Lobe Epilepsy.
    Wang X; Sha L; Sun N; Shen Y; Xu Q
    Mol Neurobiol; 2017 Jan; 54(1):175-187. PubMed ID: 26732600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotypes within non-surgical patients with mesial temporal lobe epilepsy caused by hippocampal sclerosis based on response to antiepileptic drugs.
    Gomez-Ibañez A; Gasca-Salas C; Urrestarazu E; Viteri C
    Seizure; 2013 Jan; 22(1):20-3. PubMed ID: 23041032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.